Real-world efficiency of lenvatinib plus PD-1 blockades in advanced hepatocellular carcinoma: an exploration for expanded indications

Overview of attention for article published in BMC Cancer, March 2022

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 20 Dimensions

Readers on

mendeley: 12 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 1 X users, with an upper bound of 906 followers.

New article: Real-world efficiency of lenvatinib plus PD-1 blockades in advanced hepatocellular carcinoma: an exploration for expanded indications https://t.co/vor85Ko7Ro #pancreaticcancer #oncology https://t.co/yZ8tSGd9T0

Reply Repost Favourite

New article: Real-world efficiency of lenvatinib plus PD-1 blockades in advanced hepatocellular carcinoma: an exploration for expanded indications https://t.co/KdE4L1J5RD #livercancer #oncology https://t.co/2d18jrE9lo

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.